D Farge

Summary

Country: France

Publications

  1. ncbi [Stem cell transplantation in autoimmune diseases]
    L Florea
    Rev Med Interne 29:80-3. 2008
  2. ncbi Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry
    D Farge
    St Louis Hospital, Paris, France
    Ann Rheum Dis 63:974-81. 2004
  3. ncbi [Mesenchymal stem cells and immunomodulation: toward new immunosuppressive strategies for the treatment of autoimmune diseases?]
    J Larghero
    Unité de Thérapie Cellulaire, Hopital Saint Louis, AP HP, Paris, France
    Rev Med Interne 30:287-99. 2009
  4. ncbi [Follow-up with the assistance of TB-info software of 208 tuberculosis patients who were treated in 2004]
    A Bourgarit
    Hopital Saint Louis, Paris, France
    Rev Med Interne 30:841-6. 2009
  5. ncbi Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes
    L Vija
    INSERM U697, Paris, France
    Diabetes Metab 35:85-93. 2009
  6. ncbi Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis
    J Larghero
    Cell Therapy Unit, Assistance Publique Hopitaux de Paris, Saint Louis Hospital, Paris, France
    Ann Rheum Dis 67:443-9. 2008
  7. ncbi Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database
    Christian Pagnoux
    Universite Paris Descartes, Hopital Cochin, Assistance Publique Hopitaux de Paris, Paris, France
    Arthritis Rheum 62:616-26. 2010
  8. ncbi Skin involvement in scleroderma--where histological and clinical scores meet
    F Verrecchia
    INSERM U697, Paris, France
    Rheumatology (Oxford) 46:833-41. 2007
  9. ncbi [Cytokines in systemic sclerosis]
    J Baraut
    hôpital Saint Louis pavillon Bazin, Paris, France
    Pathol Biol (Paris) 60:127-39. 2012
  10. ncbi Diagnostic value of a nested polymerase chain reaction assay on peripheral blood mononuclear cells from patients with pulmonary and extra-pulmonary tuberculosis
    S Honore
    Service de Microbiologie, Hopital Saint Louis, Paris, France
    Int J Tuberc Lung Dis 5:754-62. 2001

Detail Information

Publications23

  1. ncbi [Stem cell transplantation in autoimmune diseases]
    L Florea
    Rev Med Interne 29:80-3. 2008
  2. ncbi Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry
    D Farge
    St Louis Hospital, Paris, France
    Ann Rheum Dis 63:974-81. 2004
    ..This EBMT/EULAR report describes the longer outcome of patients originally described in addition to newly recruited cases...
  3. ncbi [Mesenchymal stem cells and immunomodulation: toward new immunosuppressive strategies for the treatment of autoimmune diseases?]
    J Larghero
    Unité de Thérapie Cellulaire, Hopital Saint Louis, AP HP, Paris, France
    Rev Med Interne 30:287-99. 2009
    ..Phase I-II studies are in progress in various countries to investigate the potential benefit from MSC due to their immunosuppressive properties, as an adjunctive therapy for severe refractory autoimmune disease...
  4. ncbi [Follow-up with the assistance of TB-info software of 208 tuberculosis patients who were treated in 2004]
    A Bourgarit
    Hopital Saint Louis, Paris, France
    Rev Med Interne 30:841-6. 2009
    ..The impact of the TB-info software was assessed on the care of patients treated with antituberculosis regimen (ATT)...
  5. ncbi Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes
    L Vija
    INSERM U697, Paris, France
    Diabetes Metab 35:85-93. 2009
    ..In this review, we provide a brief characterization of MSC immunomodulatory effects, and present the current experimental evidence for the potential therapeutic efficacy of MSC transplantation in diabetes...
  6. ncbi Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis
    J Larghero
    Cell Therapy Unit, Assistance Publique Hopitaux de Paris, Saint Louis Hospital, Paris, France
    Ann Rheum Dis 67:443-9. 2008
    ..Mesenchymal stem cells (MSCs) have a potential immunomodulatory role in autoimmune disease; however, the qualitative properties and haematopoietic support capacity of MSCs derived from patients with autoimmune disease is unclear...
  7. ncbi Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database
    Christian Pagnoux
    Universite Paris Descartes, Hopital Cochin, Assistance Publique Hopitaux de Paris, Paris, France
    Arthritis Rheum 62:616-26. 2010
    ..This study was undertaken to describe the main characteristics of and long-term outcomes in patients with well-characterized PAN diagnoses...
  8. ncbi Skin involvement in scleroderma--where histological and clinical scores meet
    F Verrecchia
    INSERM U697, Paris, France
    Rheumatology (Oxford) 46:833-41. 2007
    ....
  9. ncbi [Cytokines in systemic sclerosis]
    J Baraut
    hôpital Saint Louis pavillon Bazin, Paris, France
    Pathol Biol (Paris) 60:127-39. 2012
    ..The restoration of the Th1/Th2/Th17/Treg balance will contribute to the effectiveness of treatment and the use of cytokine modulators may therefore be considered in developing new therapeutic approaches...
  10. ncbi Diagnostic value of a nested polymerase chain reaction assay on peripheral blood mononuclear cells from patients with pulmonary and extra-pulmonary tuberculosis
    S Honore
    Service de Microbiologie, Hopital Saint Louis, Paris, France
    Int J Tuberc Lung Dis 5:754-62. 2001
    ..However, further studies are needed to confirm this technique as an alternative test for the diagnosis of paucibacillary forms of tuberculosis...
  11. ncbi European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research
    J Avouac
    Rheumatology A Department, RDU, Paris, France
    Ann Rheum Dis 68:629-34. 2009
    ..In particular, the results of a web-based Delphi exercise aimed at selection of research questions and evidence from systematic literature research, as parts of the development of these recommendations, are presented in detail...
  12. ncbi Azathioprine or methotrexate maintenance for ANCA-associated vasculitis
    Christian Pagnoux
    Universite Paris Descartes, Hopital Cochin, Assistance Publique Hopitaux de Paris, Paris, France
    N Engl J Med 359:2790-803. 2008
    ..However, azathioprine and methotrexate have not been compared with regard to safety and efficacy...
  13. ncbi Tuberculosis in European cities: establishment of a patient monitoring system over 10 years in Paris, France
    D Farge
    Service de médecine interne et pathologie vasculaire, Hopital Saint Louis, Paris, France
    Int J Tuberc Lung Dis 11:992-8. 2007
    ..France has been unable to report on treatment outcomes until now, and it is not known whether the World Health Organization (WHO) target cure rate of 85% has been met...
  14. ncbi [Cardiopulmonary function before and after cyclophosphamide treatment in severe systemic sclerosis: comparison of monthly intravenous bolus and autologous haematopoietic stem cell transplantation]
    C Toledano
    Service de Medecine Interne, Hopital Saint Louis, Paris, France
    Rev Med Interne 26:444-52. 2005
    ..Cyclophosphamide potential cardiotoxicity in this setting has been questioned...
  15. ncbi [All colors on a black skin!]
    A Gallet
    , , Paris, France
    Rev Med Interne 26:S299-301. 2005
  16. ncbi [Therapeutic intensification and autologous stem cell transplantation in autoimmune diseases]
    Z Marjanovic
    , Service de Greffe de Moelle, , 1, avenue Claude Vellefaux, 75010 Paris, France
    Presse Med 34:311-8. 2005
    ..A STUDY PROJECT IS PLANNED FOR MULTIPLE SCLEROSIS (Astims, Autologous Stem cell Transplantation International Multiple Sclerosis)...
  17. ncbi [Quality of life assessment with the MOS-SF36 in patients with systemic sclerosis]
    C Georges
    Service de Medecine Interne, Hopital Saint Louis, 1, avenue Claude Vellefaux, 75475 Paris 10, France
    Rev Med Interne 25:16-21. 2004
    ....
  18. ncbi Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ)
    C Georges
    AP HP, Internal Medicine, Saint Louis Hospital, 1 avenue Claude Vellefaux, 75010 Paris, France
    Clin Rheumatol 24:3-10. 2005
    ..In addition, we suggest the use of a new outcome measure, the SSc HAQ score, to assess this systemic disease more accurately...
  19. ncbi Autologous Stem cell Transplantation International Scleroderma (ASTIS) trial: hope on the horizon for patients with severe systemic sclerosis
    J M van Laar
    Ann Rheum Dis 64:1515. 2005
  20. ncbi [Bone marrow transplantation in the treatment of autoimmune disease]
    D Farge
    , , INSERM U697, 1 avenue Claude-Vellefaux, 75010 Paris, France
    Rev Med Interne 28:S285-7. 2007
  21. ncbi Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis
    M C Vonk
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, P O Box 9101, 6500 HB Nijmegen, The Netherlands
    Ann Rheum Dis 67:98-104. 2008
    ..This study reports the effects on survival, skin and major organ function of HSCT in patients with severe diffuse cutaneous SSc...
  22. ncbi Impact of pain in health related quality of life of patients with systemic sclerosis
    C Georges
    Internal Medicine Department, Saint Louis Hospital, Service de Medecine Interne, Hopital Saint Louis, 1 avenue Claude Vellefaux, 75010 Paris, France
    Rheumatology (Oxford) 45:1298-302. 2006
    ..The aim of the study is as to evaluate the quality of life (QoL) in patients with either diffuse or limited SSc, and to examine the impact of pain on the QoL scores...
  23. ncbi Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
    M Binks
    Royal Free Hospital, London
    Ann Rheum Dis 60:577-84. 2001
    ..If future trials incorporate inclusion and exclusion criteria based on this preliminary experience, the predicted procedure related mortality should be around 10%...